An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present)

References

• Fingleton B. Matrix metalloproteinases as valid clinical targets. Curr Pharm Des. 2007;13(3):333–336. doi: 10.2174/138161207779313551
   PubMed Web of Science ®Google Scholar
• Davies B, Brown PD, East N, et al. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 1993;53(9):2087–2091.
   PubMed Web of Science ®Google Scholar
• Wojtowicz-Praga SM, Dickson RB, Hawkins MJ. Matrix metalloproteinase inhibitors. Invest New Drugs. 1997;15(1):61–75. doi: 10.1023/a:1005722729132
   PubMed Web of Science ®Google Scholar
• Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst. 2001;93(3):178–193. doi: 10.1093/jnci/93.3.178
   PubMed Web of Science ®Google Scholar
• Dove A. MMP inhibitors: glimmers of hope amidst clinical failures. Nat Med. 2002;8(2):95. doi: 10.1038/nm0202-95
   PubMed Web of Science ®Google Scholar
• Li NG, Tang YP, Duan JA, et al. Matrix metalloproteinase inhibitors: a patent review (2011-2013). Expert Opin Ther Pat. 2014;24(9):1039–1052. doi: 10.1517/13543776.2014.937424
   PubMed Web of Science ®Google Scholar
• Li X. Gelatinase inhibitors: a patent review (2011-2017). Expert Opin Ther Pat. 2018;28(1):31–46. doi: 10.1080/13543776.2018.1397132
   PubMed Web of Science ®Google Scholar
• Baidya SK, Amin SA, Jha T. Outline of gelatinase inhibitors as anti-cancer agents: a patent mini-review for 2010-present. Eur J Med Chem. 2021;213:113044.
   PubMed Web of Science ®Google Scholar
• Lenci E, Cosottini L, Trabocchi A. Novel matrix metalloproteinase inhibitors: an updated patent review (2014-2020). Expert Opin Ther Pat. 2021;31(6):509–523. doi: 10.1080/13543776.2021.1881481
   PubMed Web of Science ®Google Scholar
• Li X, Wu JF. Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs). Recent Pat Anticancer Drug Discov. 2010;5(2):109–141. doi: 10.2174/157489210790936234
   PubMed Web of Science ®Google Scholar
• Shi ZG, Li JP, Shi LL, et al. An updated patent therapeutic agents targeting MMPs. Recent Pat Anticancer Drug Discov. 2012;7(1):74–101. doi: 10.2174/157489212798357976
   PubMed Web of Science ®Google Scholar
• Beckett RP, Whittaker M. Matrix metalloproteinase inhibitors 1998. Expert Opin Ther Pat. 1998;8(3):259–282. doi: 10.1517/13543776.8.3.259
   Web of Science ®Google Scholar
• Li NG, Tang YP, Duan JA, et al. Matrix metalloproteinase inhibitors: a patent review (2011–2013). Expert Opin Ther Pat. 2014;24(9):1039–1052. doi: 10.1517/13543776.2014.937424
   PubMed Web of Science ®Google Scholar
• Fields GB. The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma. Cells. 2019;8(9):984. doi: 10.3390/cells8090984
   PubMed Web of Science ®Google Scholar
• Vandenbroucke RE, Libert C. Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov. 2014;13(12):904–927. doi: 10.1038/nrd4390
   PubMed Web of Science ®Google Scholar
• Rudek MA, Venitz J, Figg WD. Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy? Pharmacother. 2002;22(6):705–720. doi: 10.1592/phco.22.9.705.34062
   PubMed Web of Science ®Google Scholar
• Baidya SK, Banerjee S, Adhikari N, et al. Selective inhibitors of medium-size S1’ pocket matrix metalloproteinases: a stepping stone of future drug discovery. J Med Chem. 2022;65(16):10709–10754. doi: 10.1021/acs.jmedchem.1c01855
   PubMed Web of Science ®Google Scholar
• Camodeca C, Cuffaro D, Nuti E, et al. ADAM metalloproteinases as potential drug targets. Curr Med Chem. 2019;26(15):2661–2689. doi: 10.2174/0929867325666180326164104
   PubMed Web of Science ®Google Scholar
• Winum JY, Supuran CT. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem. 2015;30(2):321–324. doi: 10.3109/14756366.2014.913587
   PubMed Web of Science ®Google Scholar
• Cuffaro D, Ciccone L, Rossello A, et al. Targeting aggrecanases for osteoarthritis therapy: from zinc chelation to exosite inhibition. J Med Chem. 2022;65(20):13505–13532. doi: 10.1021/acs.jmedchem.2c01177
   PubMed Web of Science ®Google Scholar
• Adhikari N, Amin SA, Ghosh B, et al. Shedding light on designing potential meprin β inhibitors through ligand-based robust validated computational approaches: a proposal to chemists! J Biomol Struct Dyn. 2018;36(11):3003–22 2018. doi: 10.1080/07391102.2017.1374210
   PubMed Web of Science ®Google Scholar
• Adhikari N, Mukherjee A, Saha A, et al. Arylsulfonamides and selectivity of matrix metalloproteinase-2: an overview. Eur J Med Chem. 2017;129:72–109. doi: 10.1016/j.ejmech.2017.02.014
   PubMed Web of Science ®Google Scholar
• Sui J, Huang J, Zhang Y. The MMP-1 gene rs1799750 Polymorphism is associated with breast cancer risk. Genet Test Mol Biomarkers. 2021;25(7):496–503. doi: 10.1089/gtmb.2021.0016
   PubMed Web of Science ®Google Scholar
• Bendardaf R, Buhmeida A, Ristamäki R, et al. MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases. Scand J Gastroenterol. 2007;42(12):1473–1478. doi: 10.1080/00365520701485449
   PubMed Web of Science ®Google Scholar
• Zhong WD, Han ZD, He HC, et al. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. Oncol. 2008;75(3–4):230–236. doi: 10.1159/000163852
   Google Scholar
• Ghaffarzadeh A, Bagheri M, Khadem-Vatani K, et al. Association of MMP-1 (rs1799750)-1607 2G/2G and MMP-3 (rs3025058)-1612 6A/6A genotypes with coronary artery disease risk among iranian turks. J Cardiovasc Pharmacol. 2019;74(5):420–425. doi: 10.1097/FJC.0000000000000727
   PubMed Web of Science ®Google Scholar
• Zhang C, Chen L, Gu Y. Polymorphisms of MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis. A meta-analysis. Z Rheumatol. 2015;74(3):258–262. doi: 10.1007/s00393-014-1537-2
   PubMed Web of Science ®Google Scholar
• Geraghty P, Dabo AJ, D’Armiento J. TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J Biol Chem. 2011;286(34):30211–30218. doi: 10.1074/jbc.M111.238824
   PubMed Web of Science ®Google Scholar
• Gupta V, Singh MK, Garg RK, et al. Evaluation of peripheral matrix metalloproteinase-1 in Parkinson’s disease: a case-control study. Int J Neurosci. 2014;124(2):88–92. doi: 10.3109/00207454.2013.824438
   PubMed Web of Science ®Google Scholar
• Köhrmann A, Kammerer U, Kapp M, et al. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: new findings and review of the literature. BMC Cancer. 2009;9:188. doi: 10.1186/1471-2407-9-188
   PubMed Web of Science ®Google Scholar
• Laitinen A, Hagström J, Mustonen H, et al. Serum MMP-8 and TIMP-1 as prognostic biomarkers in gastric cancer. Tumour Biol. 2018;40(9):1010428318799266. doi: 10.1177/1010428318799266
   Google Scholar
• Mattey DL, Nixon NB, Dawes PT. Association of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis. Arthritis Res Ther. 2012;14(5):R204. doi: 10.1186/ar4042
   PubMed Web of Science ®Google Scholar
• Lenglet S, Mach F, Montecucco F. Role of matrix metalloproteinase-8 in atherosclerosis. Mediators Inflamm. 2013;2013:659282. doi: 10.1155/2013/659282
   PubMed Web of Science ®Google Scholar
• Cárcel-Márquez J, Cullell N, Muiño E, et al. Causal effect of MMP-1 (matrix metalloproteinase-1), MMP-8, and MMP-12 levels on ischemic stroke: a mendelian randomization study. Stroke. 2021;52(7):e316–20. doi: 10.1161/STROKEAHA.120.033041
   PubMed Web of Science ®Google Scholar
• Zhang L, Li X, Yan H, et al. Salivary matrix metalloproteinase (MMP)-8 as a biomarker for periodontitis: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2018;97(3):e9642. doi: 10.1097/MD.0000000000009642
   PubMed Web of Science ®Google Scholar
• Hu Q, Ecker M. Overview of MMP-13 as a promising target for the treatment of osteoarthritis. Int J Mol Sci. 2021;22(4):1742. doi: 10.3390/ijms22041742
   PubMed Web of Science ®Google Scholar
• Wang SW, Tai HC, Tang CH, et al. Melatonin impedes prostate cancer metastasis by suppressing MMP-13 expression. J Cell Physiol. 2021;236(5):3979–3990. doi: 10.1002/jcp.30150
   PubMed Web of Science ®Google Scholar
• Kotepui M, Punsawad C, Chupeerach C, et al. Differential expression of matrix metalloproteinase-13 in association with invasion of breast cancer. Contemp Oncol (Pozn). 2016;20(3):225–228. doi: 10.5114/wo.2016.61565
   PubMedGoogle Scholar
• Jin D, Tao J, Li D, et al. Golgi protein 73 activation of MMP-13 promotes hepatocellular carcinoma cell invasion. Oncotarget. 2015;6(32):33523–33533. doi: 10.18632/oncotarget.5590
   PubMedGoogle Scholar
• Zapico JM, Acosta L, Pastor M, et al. Design and synthesis of water-soluble and potent mmp-13 inhibitors with activity in human osteosarcoma cells. Int J Mol Sci. 2021;22(18):9976. doi: 10.3390/ijms22189976
   PubMed Web of Science ®Google Scholar
• Waldron AL, Schroder PA, Bourgon KL, et al. Oxidative stress-dependent MMP-13 activity underlies glucose neurotoxicity. J Diabetes Complications. 2018;32(3):249–257. doi: 10.1016/j.jdiacomp.2017.11.012
   PubMed Web of Science ®Google Scholar
• Howell C, Smith JR, Shute JK. Targeting matrix metalloproteinase-13 in bronchial epithelial repair. Clin Exp Allergy. 2018;48(9):1214–1221. doi: 10.1111/cea.13215
   PubMed Web of Science ®Google Scholar
• Uchinami H, Seki E, Brenner DA, et al. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology. 2006;44(2):420–429. doi: 10.1002/hep.21268
   PubMed Web of Science ®Google Scholar
• Overall CM, López-Otín C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer. 2002;2(9):657–672. doi: 10.1038/nrc884
   PubMed Web of Science ®Google Scholar
• Noh S, Jung JJ, Jung M, et al. MMP-2 as a putative biomarker for carcinomatosis in gastric cancer. Hepatogastroenterology. 2011;58(112):2015–2019. doi: 10.5754/hge11209
   PubMedGoogle Scholar
• Murnane MJ, Cai J, Shuja S, et al. Active MMP-2 effectively identifies the presence of colorectal cancer. Int J Cancer. 2009;125(12):2893–2902. doi: 10.1002/ijc.24682
   PubMed Web of Science ®Google Scholar
• Hu J, Van den Steen PE, Sang QX, et al. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov. 2007;6(6):480–498. doi: 10.1038/nrd2308
   PubMed Web of Science ®Google Scholar
• Levin M, Udi Y, Solomonov I, et al. Next generation matrix metalloproteinase inhibitors - novel strategies bring new prospects. Biochim Biophys Acta, Mol Cell Res. 2017;1864(11 Pt A):1927–1939. doi: 10.1016/j.bbamcr.2017.06.009
   PubMed Web of Science ®Google Scholar
• Kurzepa J, Mądro A, Czechowska G, et al. Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases. Hepatobiliary Pancreat Dis Int. 2014;13(6):570–579. doi: 10.1016/s1499-3872(14)60261-7
   PubMed Web of Science ®Google Scholar
• Chang YH, Lin IL, Tsay GJ, et al. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Biochem. 2008;41(12):955–959. doi: 10.1016/j.clinbiochem.2008.04.012
   PubMed Web of Science ®Google Scholar
• Mondal S, Adhikari N, Banerjee S, et al. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview. Eur J Med Chem. 2020;194:112260. doi: 10.1016/j.ejmech.2020.112260
   PubMed Web of Science ®Google Scholar
• Huang H. Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances.sensors (basel). 2018;18(10):3249.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Gao M, Lin D, et al. Prognostic and immunological roles of MMP-9 in pan-cancer. Biomed Res Int. 2022;2022:1–32. doi: 10.1155/2022/2592962
   Web of Science ®Google Scholar
• Jayashree K, Yasir M, Senthilkumar GP, et al. Circulating matrix modulators (MMP-9 and TIMP-1) and their association with severity of diabetic retinopathy. Diabetes Metab Syndr. 2018;12(6):869–873. doi: 10.1016/j.dsx.2018.05.006
   PubMed Web of Science ®Google Scholar
• Siloşi I, Boldeanu MV, Mogoantă SŞ, et al. Matrix metalloproteinases (MMP-3 and MMP-9) implication in the pathogenesis of inflammatory bowel disease (IBD). Rom J Morphol Embryol. 2014;55(4):1317–1324.
   PubMed Web of Science ®Google Scholar
• Opdenakker G, Nelissen I, Van Damme J. Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis. Lancet Neurol. 2003;2(12):747–756. doi: 10.1016/s1474-4422(03)00587-8
   PubMed Web of Science ®Google Scholar
• Radosinska J, Barancik M, Vrbjar N. Heart failure and role of circulating MMP-2 and MMP-9. Panminerva Med. 2017;59(3):241–253. doi: 10.23736/S0031-0808.17.03321-3
   PubMed Web of Science ®Google Scholar
• Liu Y, Min D, Bolton T, et al. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care. 2009;32(1):117–119. doi: 10.2337/dc08-0763
   PubMed Web of Science ®Google Scholar
• Uysal P, Uzun H. Relationship between circulating serpina3g, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 and -2 with chronic obstructive pulmonary disease severity. Biomolecules. 2019;9(2):62. doi: 10.3390/biom9020062
   PubMed Web of Science ®Google Scholar
• Matson SM, Lee SJ, Peterson RA, et al. The prognostic role of matrix metalloproteinase-7 in scleroderma-associated interstitial lung disease. Eur Respir J. 2021;58(6):2101560. doi: 10.1183/13993003.01560-2021
   PubMed Web of Science ®Google Scholar
• Surendran K, Simon TC, Liapis H, et al. Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4. Kidney Int. 2004;65(6):2212–2222. doi: 10.1111/j.1523-1755.2004.00641.x
   PubMed Web of Science ®Google Scholar
• Liu Z, Tan RJ, Liu Y. The many faces of matrix metalloproteinase-7 in kidney diseases. Biomolecules. 2020;10(6):960. doi: 10.3390/biom10060960
   PubMed Web of Science ®Google Scholar
• Lwin ST, Fowler JA, Drake MT, et al. A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo. Mol Cancer. 2017;16(1):49. doi: 10.1186/s12943-017-0616-9
   PubMedGoogle Scholar
• Nilsson L, Jonasson L, Nijm J, et al. Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease. Clin Chem. 2006;52(8):1522–1527. doi: 10.1373/clinchem.2006.067439
   PubMed Web of Science ®Google Scholar
• Argote Camacho AX, González Ramírez AR, Pérez Alonso AJ, et al. Metalloproteinases 1 and 3 as potential biomarkers in breast cancer development. Int J Mol Sci. 2021;22(16):9012. doi: 10.3390/ijms22169012
   PubMed Web of Science ®Google Scholar
• Kreus M, Lehtonen S, Skarp S, et al. Extracellular matrix proteins produced by stromal cells in idiopathic pulmonary fibrosis and lung adenocarcinoma. PLoS One. 2021;16(4):e0250109. doi: 10.1371/journal.pone.0250109
   PubMed Web of Science ®Google Scholar
• Eyyupkoca F, Sabanoglu C, Altintas MS, et al. Higher levels of TWEAK and matrix metalloproteinase-3 during the acute phase of myocardial infarction are associated with adverse left ventricular remodeling. Postepy Kardiol Interwencyjnej. 2021;17(4):356–365. doi: 10.5114/aic.2021.111967
   PubMed Web of Science ®Google Scholar
• Mirtaheri E, Khabbazi A, Nazemiyeh H, et al. Stachys schtschegleevii tea, matrix metalloproteinase, and disease severity in female rheumatoid arthritis patients: a randomized controlled clinical trial. Clin Rheumatol. 2022;41(4):1033–1044. doi: 10.1007/s10067-021-05981-4
   PubMed Web of Science ®Google Scholar
• Hashimoto H, Hashimoto S, Shimazaki Y. Functional impairment and periodontitis in rheumatoid arthritis. Int Dent J. 2022;72(5):641–647. doi: 10.1016/j.identj.2022.01.002
   PubMed Web of Science ®Google Scholar
• Ordak M, Libman-Sokolowska M, Nasierowski T, et al. Matrix metalloproteinase-3 serum levels in schizophrenic patients. Int J Psychiatry Clin Pract. 2023;27(1):1–7. doi: 10.1080/13651501.2022.2057332
   PubMed Web of Science ®Google Scholar
• Choudhary P, Roy T, Chatterjee A, et al. Melatonin rescues swim stress induced gastric ulceration by inhibiting matrix metalloproteinase-3 via down-regulation of inflammatory signaling cascade. Life Sci. 2022;297:120426. doi: 10.1016/j.lfs.2022.120426
   PubMed Web of Science ®Google Scholar
• Ma B, Ran R, Liao HY, et al. The paradoxical role of matrix metalloproteinase-11 in cancer. Biomed Pharmacother. 2021;141:111899. doi: 10.1016/j.biopha.2021.111899
   PubMed Web of Science ®Google Scholar
• Matziari M, Dive V, Yiotakis A. Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors. Med Res Rev. 2007;27(4):528–552. doi: 10.1002/med.20066
   PubMed Web of Science ®Google Scholar
• Chen N, Zhang G, Fu J, et al. Matrix metalloproteinase-14 (MMP-14) downregulation inhibits esophageal squamous cell carcinoma cell migration, invasion, and proliferation. Thorac Cancer. 2020;11(11):3168–3174. doi: 10.1111/1759-7714.13636
   PubMed Web of Science ®Google Scholar
• Kasurinen A, Tervahartiala T, Laitinen A, et al. High serum MMP-14 predicts worse survival in gastric cancer. PLoS One. 2018;13(12):e0208800. doi: 10.1371/journal.pone.0208800
   PubMed Web of Science ®Google Scholar
• Wang YZ, Wu KP, Wu AB, et al. MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer. Tumour Biol. 2014;35(10):9815–9821. doi: 10.1007/s13277-014-2237-x
   PubMedGoogle Scholar
• Di D, Chen L, Guo Y, et al. Association of BCSC-1 and MMP-14 with human breast cancer. Oncol Lett. 2018;15(4):5020–5026. doi: 10.3892/ol.2018.7972
   PubMedGoogle Scholar
• Morcillo MÁ, García de Lucas Á, Oteo M, et al. MT1-MMP as a PET imaging biomarker for pancreas cancer management. Contrast Media Mol Imaging. 2018;2018:8382148. doi: 10.1155/2018/8382148
   PubMedGoogle Scholar
• Kanazawa A, Oshima T, Yoshihara K, et al. Relation of MT1-MMP gene expression to outcomes in colorectal cancer. J Surg Oncol. 2010;102(6):571–575. doi: 10.1002/jso.21703
   PubMed Web of Science ®Google Scholar
• Lin J, Davis HB, Dai Q, et al. Effects of early and late chronic pressure overload on extracellular matrix remodeling. Hypertens Res. 2008;31(6):1225–1231. doi: 10.1291/hypres.31.1225
   PubMed Web of Science ®Google Scholar
• Ünal A, Baykal O, Öztürk N. Comparison of matrix metalloproteinase 9 and 14 levels in vitreous samples in diabetic and non-diabetic patients: a case control study. Int J Retina Vitreous. 2022;8(1):44. doi: 10.1186/s40942-022-00394-0
   PubMedGoogle Scholar
• Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience. 2009;158(3):983–994. doi: 10.1016/j.neuroscience.2008.06.025
   PubMed Web of Science ®Google Scholar
• Lagente V, Le Quement C, Boichot E. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases. Expert Opin Ther Targets. 2009;13(3):287–295. doi: 10.1517/14728220902751632
   PubMed Web of Science ®Google Scholar
• Nénan S, Boichot E, Lagente V, et al. Macrophage elastase (MMP-12): a pro-inflammatory mediator? Mem Inst Oswaldo Cruz. 2005;100:167–172. doi: 10.1590/s0074-02762005000900028
   PubMed Web of Science ®Google Scholar
• Abd-Elaziz K, Jesenak M, Vasakova M, et al. Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases. Curr Opin Pulm Med. 2021;27(1):54–60. doi: 10.1097/MCP.0000000000000743
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Sypek J, Tavendale R, et al. Matrix metalloproteinase-12 is a therapeutic target for asthma in children and young adults. J Allergy Clin Immunol. 2010;126(1):70–6.e16. doi: 10.1016/j.jaci.2010.03.027
   PubMed Web of Science ®Google Scholar
• Zhou Y, Xu M, Gong W, et al. Circulating MMP-12 as potential biomarker in evaluating disease severity and efficacy of sublingual immunotherapy in allergic rhinitis. Mediators Inflamm 3378035. 2022;2022:1–10. doi: 10.1155/2022/3378035
   Web of Science ®Google Scholar
• Hofmann HS, Hansen G, Richter G, et al. Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res. 2005;11(3):1086–1092. doi: 10.1158/1078-0432.1086.11.3
   PubMed Web of Science ®Google Scholar
• Zheng J, Chu D, Wang D, et al. Matrix metalloproteinase-12 is associated with overall survival in Chinese patients with gastric cancer. J Surg Oncol. 2013;107(7):746–751. doi: 10.1002/jso.23302
   PubMed Web of Science ®Google Scholar
• Polonskaya YV, Kashtanova EV, Murashov IS, et al. Association of matrix metalloproteinases with coronary artery calcification in patients with CHD. J Pers Med. 2021;11(6):506. doi: 10.3390/jpm11060506
   PubMed Web of Science ®Google Scholar
• Jguirim-Souissi I, Jelassi A, Slimani A, et al. Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease. Coron Artery Dis. 2011;22(6):388–393. doi: 10.1097/MCA.0b013e3283478d40
   PubMed Web of Science ®Google Scholar
• Chen YE. MMP-12, an old enzyme plays a new role in the pathogenesis of rheumatoid arthritis? Am J Pathol. 2004;165(4):1069–1070. doi: 10.1016/S0002-9440(10)63368-8
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Saarialho-Kere U, Buckley MG, et al. Stromelysin-1 and macrophage metalloelastase expression in the intestinal mucosa of Crohn’s disease patients treated with infliximab. Eur J Gastroenterol Hepatol. 2009;21(9):1049–1055. doi: 10.1097/MEG.0b013e3283293d0f
   PubMed Web of Science ®Google Scholar
• Salmela MT, Pender SL, Reunala T, et al. Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis. Gut. 2001;48(4):496–502. doi: 10.1136/gut.48.4.496
   PubMed Web of Science ®Google Scholar
• Florida Atlantic University Board of Trustees. Selective matrix metalloproteinase-13 inhibitors. US. 2020;A1. 2020/0181095.
   Google Scholar
• DSM IP assets B.V. 6411 TE Heerlen (NL). Phosphinic peptide derivatives for use as MMP-3 inhibitors. 2021;EP3881821A1.
   Google Scholar
• Chem-master international inc, research foundation of state university of new york. Curcumin analogues as zinc chelators and their usesp. US11608309B2 (2023).
   Google Scholar
• University Y. US department of veterans affairs VA. Matrix metalloproteinase inhibitors and imaging agents, and methods using same. 2022;US20220194930A1.
   Google Scholar
• University B. Matrix metalloproteinase inhibitors (MMPIs). 2023;US20230104690A1.
   Google Scholar
• The University Of Birmingham. MMP-9 and MMP-12 inhibition for treating spinal cord injury or related injury to neurological tissue. 2021. p. WO2021260387A1.
   Google Scholar
• Foresee Pharmaceuticals Co., Ltd. Safe administration of mmp-12 inhibitorp. WO2022261624A1 (2022).
   Google Scholar
• Vasa Therapeutics Spółka Z Ograniczoną Odpowiedzialnością. Diazabicyclooctane derivatives useful as matrix metalloproteinase inhibitorsp. WO2023062492A1 (2023).
   Google Scholar
• Taisho Pharmaceutical Co., Ltd. Sulfonamide having MMP 7-inhibiting action. 2022. p. WO2022234867A1.
   Google Scholar
• Adhikari N, Amin SA, Saha A, et al. Structural exploration for the refinement of anticancer matrix metalloproteinase-2 inhibitor designing approaches through robust validated multi-QSARs. J Mol Struct. 2018;1156:501–515. doi: 10.1016/j.molstruc.2017.12.005
   Web of Science ®Google Scholar
• Jha T, Adhikari N, Saha A, et al. Multiple molecular modelling studies on some derivatives and analogues of glutamic acid as matrix metalloproteinase-2 inhibitors. SAR QSAR Env Res. 2018;29(1):43–68. doi: 10.1080/1062936X.2017.1406986
   PubMed Web of Science ®Google Scholar
• Guti S, Baidya SK, Banerjee S, et al. A robust classification-dependent multi-molecular modelling study on some biphenyl sulphonamide based MMP-8 inhibitors. SAR QSAR Env Res. 2021;32(10):835–861. doi: 10.1080/1062936X.2021.1976831
   PubMed Web of Science ®Google Scholar
• Tamang JSD, Banerjee S, Baidya SK, et al. Employing comparative QSAR techniques for the recognition of dibenzofuran and dibenzothiophene derivatives toward MMP-12 inhibition. J Biomol Struct Dyn. 2023;1–17. doi: 10.1080/07391102.2023.2239923
   PubMed Web of Science ®Google Scholar
• Banerjee S, Baidya SK, Ghosh B, et al. Exploration of structural alerts and fingerprints for novel anticancer therapeutics: a robust classification-QSAR dependent structural analysis of drug-like MMP-9 inhibitors. SAR QSAR Environ Res. 2023;34(4):299–319. doi: 10.1080/1062936X.2023.2209737
   PubMed Web of Science ®Google Scholar
• Mondal S, Banerjee S, Amin SA, et al. Structural analysis of arylsulfonamide-based carboxylic acid derivatives: a QSAR study to identify the structural contributors toward their MMP-9 inhibition. Struct Chem. 2021;32:417–430. doi: 10.1007/s11224-020-01635-4
   Web of Science ®Google Scholar
• Huang S, Feng K, Ren Y. Molecular modelling studies of quinazolinone derivatives as MMP-13 inhibitors by QSAR, molecular docking and molecular dynamics simulations techniques. MedChemcomm. 2018;10(1):101–115. doi: 10.1039/c8md00375k
   PubMed Web of Science ®Google Scholar